1.A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)
Dae-Won LEE ; Bhumsuk KEAM ; Keun Seok LEE ; Jin-Hee AHN ; Joohyuk SOHN ; Jin Seok AHN ; Moon Hee LEE ; Jee Hyun KIM ; Kyung Eun LEE ; Hyo Jung KIM ; Si-Young KIM ; Yeon Hee PARK ; Chan-Young OCK ; Kyung-Hun LEE ; Sae-Won HAN ; Sung-Bae KIM ; Young Hyuck IM ; Hyun Cheol CHUNG ; Do-Youn OH ; Seock-Ah IM
Cancer Research and Treatment 2023;55(2):523-530
Purpose:
This single-arm phase II trial investigate the efficacy and safety of S-1 plus oxaliplatin (SOX) in patients with metastatic breast cancer.
Materials and Methods:
Patients with metastatic breast cancer previously treated with anthracyclines and taxanes were enrolled. Patients received S-1 (40-60 mg depending on patient’s body surface area, twice a day, day 1-14) and oxaliplatin (130 mg/m2, day 1) in 3 weeks cycle until disease progression or unacceptable toxicity. The primary endpoint was objective response rate (ORR) according to Response Evaluation Criteria in Solid Tumor 1.1. Secondary endpoints included time-to-progression (TTP), duration-of-response (DoR), overall survival (OS), and adverse events.
Results:
A total of 87 patients were enrolled from 11 institutions in Korea. Hormone receptor was positive in 54 (62.1%) patients and six (6.9%) had human epidermal growth factor receptor 2–positive disease. Forty-eight patients (85.1%) had visceral metastasis and 74 (55.2%) had more than three sites of metastases. The ORR of SOX regimen was 38.5% (95% confidence interval [CI], 26.9 to 50.0) with a median TTP of 6.0 months (95% CI, 5.1 to 6.9). Median DoR and OS were 10.3 months (95% CI, 5.5 to 15.1) and 19.4 (95% CI, not estimated) months, respectively. Grade 3 or 4 neutropenia was reported in 28 patients (32.1%) and thrombocytopenia was observed in 23 patients (26.6%).
Conclusion
This phase II study showed that SOX regimen is a reasonable option in metastatic breast cancer previously treated with anthracyclines and taxanes.
2.Characteristics of pediatric rhabdomyolysis and the associated risk factors for acute kidney injury: a retrospective multicenter study in Korea
Sukdong YOO ; Min Hyun CHO ; Hee Sun BAEK ; Ji Yeon SONG ; Hye Sun LEE ; Eun Mi YANG ; Kee Hwan YOO ; Su Jin KIM ; Jae Il SHIN ; Keum Hwa LEE ; Tae-Sun HA ; Kyung Mi JANG ; Jung Won LEE ; Kee Hyuck KIM ; Heeyeon CHO ; Mee Jeong LEE ; Jin-Soon SUH ; Kyoung Hee HAN ; Hye Sun HYUN ; Il-Soo HA ; Hae Il CHEONG ; Hee Gyung KANG ; Mee Kyung NAMGOONG ; Hye-Kyung CHO ; Jae-Hyuk OH ; Sang Taek LEE ; Kyo Sun KIM ; Joo Hoon LEE ; Young Seo PARK ; Seong Heon KIM
Kidney Research and Clinical Practice 2021;40(4):673-686
Background:
The clinical features of pediatric rhabdomyolysis differ from those of the adults with rhabdomyolysis; however, multicenter studies are lacking. This study aimed to investigate the characteristics of pediatric rhabdomyolysis and reveal the risk factors for acute kidney injury (AKI) in such cases.
Methods:
This retrospective study analyzed the medical records of children and adolescents diagnosed with rhabdomyolysis at 23 hospitals in South Korea between January 2007 and December 2016.
Results:
Among 880 patients, those aged 3 to 5 years old composed the largest subgroup (19.4%), and all age subgroups were predominantly male. The incidence of AKI was 11.3%. Neurological disorders (53%) and infection (44%) were the most common underlying disorder and cause of rhabdomyolysis, respectively. The median age at diagnosis in the AKI subgroup was older than that in the non-AKI subgroup (12.2 years vs. 8.0 years). There were no significant differences in body mass index, myalgia, dark-colored urine, or the number of causal factors between the two AKI-status subgroups. The multivariate logistic regression model indicated that the following factors were independently associated with AKI: multiorgan failure, presence of an underlying disorder, strong positive urine occult blood, increased aspartate aminotransferase and uric acid levels, and reduced calcium levels.
Conclusions
Our study revealed characteristic clinical and laboratory features of rhabdomyolysis in a Korean pediatric population and highlighted the risk factors for AKI in these cases. Our findings will contribute to a greater understanding of pediatric rhabdomyolysis and may enable early intervention against rhabdomyolysis-induced AKI.
3.Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm).
Byung Gon NA ; Jong Man KIM ; Dong Kyu OH ; Kyo Won LEE ; Tae Wook KANG ; Gyu Seong CHOI ; Min Woo LEE ; Choon Hyuck David KWON ; Hyun Chul LIM ; Jae Won JOH
Annals of Surgical Treatment and Research 2017;92(5):355-360
PURPOSE: Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) has some limitations such as poor sonic window and injury to adjacent organs. The laparoscopic approach has been suggested as an alternative option. The aim of this study was to show the safety and efficacy of laparoscopic RFA for single, small (≤3 cm), and primary or recurrent HCC that is not suitable for percutaneous RFA or surgical resection. METHODS: We reviewed the cases of 37 patients (32 men and 5 women, mean age 61 ± 8.1 years) who underwent laparoscopic RFA for single, small HCC (≤3 cm) that was unsuitable for percutaneous RFA or surgical resection. RESULTS: The technical success rate was 94.6% and 34 patients (95%) had no complications. There were no conversions to open RFA and no operative mortality. The primary effectiveness rate 1 month after the procedure was 100%. The overall recurrence rates at 3, 6, 12, and 24 months after the laparoscopic RFA were 8.1%, 14.4%, 25%, and 35.7%, respectively. The local tumor progression rate was 4.2% at 6 months and 8.7% at 9 months. CONCLUSION: Laparoscopic RFA is a safe and effective treatment for HCC cases that are unsuitable for percutaneous RFA.
Carcinoma, Hepatocellular*
;
Catheter Ablation*
;
Female
;
Humans
;
Laparoscopy
;
Male
;
Mortality
;
Neoplasm Recurrence, Local
;
Recurrence
4.Isolation and Genetic Characterization of Orientia tsutsugamushi from Scrub Typhus Patients in Gyeongsangnam-do, Korea.
Jong Hun HA ; Dong Hae LEE ; Jin Sik PARK ; Oh Hyun CHO ; Dong Hoon KIM ; Na Young HA ; Nam Hyuck CHO ; Kyu Jam HWANG ; Yong Gon CHO ; Hye Soo LEE ; Won Kil LEE ; Yoo Chul LEE ; Myung Je CHO ; Woo Kon LEE ; Min Kyoung SHIN
Journal of Bacteriology and Virology 2016;46(4):275-282
Orientia tsutsugamushi (O. tsutsugamushi), which is endemic to an Asia-Pacific region, has increased its incidence and caused annually around 10 thousand patients infected with scrub typhus in Korea in the past several years. In the present study, we isolated 44 O. tsutsugamushi from the patients with febrile illness accompanied with or without an eschar in Gyeongsangnam-do, Korea. These isolates were characterized by genetic analysis of the major outer membrane protein, the 56-kDa type-specific antigen (tsa56), which is unique to O. tsutsugamushi. Two types of sequences of tsa56, designated by JJ1 and JJ2, were determined from 37 and 7 isolates of the 44 isolates, respectively. JJ1 and JJ2 showed 74.7~90.8% identity in nucleotide sequence and 66.1~90.5% identity in amino acid sequence with 33 reference strains except for Boryong and Kuroki. JJ1 and JJ2 had 100 and 99.9% nucleotide identity to Boryong strain, and 99.9 and 99.8% to Kuroki, which has been known to be similar to Boryong, respectively. In addition, they showed 77.9~ 81.4% nucleotide identity with the cluster of Gilliam-related genotypes, whereas they showed higher nucleotide identity (89.6~90.8%) with the cluster of Karp-related genotypes. To our knowledge, this is the first report to isolate O. tsutsugamushi and characterize their genotype as the Boryong in Jinju and West Gyeongsangnam-do, Korea, even though it has been reported that the Boryong was the predominant genotype in isolates from chiggers, domestic rodents, and patients in the southern part of Korea. Furthermore, our isolates could be useful source to study on the pathophysiology and epidemiology of scrub typhus in Korea.
Amino Acid Sequence
;
Base Sequence
;
Chungcheongnam-do
;
Epidemiology
;
Genotype
;
Gyeongsangnam-do*
;
Humans
;
Incidence
;
Korea*
;
Membrane Proteins
;
Orientia tsutsugamushi*
;
Rodentia
;
Scrub Typhus*
;
Trombiculidae
5.Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea.
Won Suk CHOI ; Cheol In KANG ; Yonjae KIM ; Jae Phil CHOI ; Joon Sung JOH ; Hyoung Shik SHIN ; Gayeon KIM ; Kyong Ran PECK ; Doo Ryeon CHUNG ; Hye Ok KIM ; Sook Hee SONG ; Yang Ree KIM ; Kyung Mok SOHN ; Younghee JUNG ; Ji Hwan BANG ; Nam Joong KIM ; Kkot Sil LEE ; Hye Won JEONG ; Ji Young RHEE ; Eu Suk KIM ; Heungjeong WOO ; Won Sup OH ; Kyungmin HUH ; Young Hyun LEE ; Joon Young SONG ; Jacob LEE ; Chang Seop LEE ; Baek Nam KIM ; Young Hwa CHOI ; Su Jin JEONG ; Jin Soo LEE ; Ji Hyun YOON ; Yu Mi WI ; Mi Kyong JOUNG ; Seong Yeon PARK ; Sun Hee LEE ; Sook In JUNG ; Shin Woo KIM ; Jae Hoon LEE ; Hyuck LEE ; Hyun Kyun KI ; Yeon Sook KIM
Infection and Chemotherapy 2016;48(2):118-126
BACKGROUND: From May to July 2015, the Republic of Korea experienced the largest outbreak of Middle East respiratory syndrome (MERS) outside the Arabian Peninsula. A total of 186 patients, including 36 deaths, had been diagnosed with MERS-coronavirus (MERS-CoV) infection as of September 30th, 2015. MATERIALS AND METHODS: We obtained information of patients who were confirmed to have MERS-CoV infection. MERS-CoV infection was diagnosed using real-time reverse-transcriptase polymerase chain reaction assay. RESULTS: The median age of the patients was 55 years (range, 16 to 86). A total of 55.4% of the patients had one or more coexisting medical conditions. The most common symptom was fever (95.2%). At admission, leukopenia (42.6%), thrombocytopenia (46.6%), and elevation of aspartate aminotransferase (42.7%) were observed. Pneumonia was detected in 68.3% of patients at admission and developed in 80.8% during the disease course. Antiviral agents were used for 74.7% of patients. Mechanical ventilation, extracorporeal membrane oxygenation, and convalescent serum were employed for 24.5%, 7.1%, and 3.8% of patients, respectively. Older age, presence of coexisting medical conditions including diabetes or chronic lung disease, presence of dyspnea, hypotension, and leukocytosis at admission, and the use of mechanical ventilation were revealed to be independent predictors of death. CONCLUSION: The clinical features of MERS-CoV infection in the Republic of Korea were similar to those of previous outbreaks in the Middle East. However, the overall mortality rate (20.4%) was lower than that in previous reports. Enhanced surveillance and active management of patients during the outbreak may have resulted in improved outcomes.
Antiviral Agents
;
Aspartate Aminotransferases
;
Coronavirus Infections*
;
Disease Outbreaks
;
Dyspnea
;
Extracorporeal Membrane Oxygenation
;
Fever
;
Humans
;
Hypotension
;
Leukocytosis
;
Leukopenia
;
Lung Diseases
;
Middle East Respiratory Syndrome Coronavirus
;
Middle East*
;
Mortality
;
Pneumonia
;
Polymerase Chain Reaction
;
Republic of Korea*
;
Respiration, Artificial
;
Thrombocytopenia
6.Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma.
Byoung Hyuck KIM ; Kyubo KIM ; Eui Kyu CHIE ; Jin Young JANG ; Sun Whe KIM ; Sae Won HAN ; Do Youn OH ; Seock Ah IM ; Tae You KIM ; Yung Jue BANG ; Ijin JOO ; Sung W HA
Cancer Research and Treatment 2015;47(2):274-281
PURPOSE: The purpose of this study was to evaluate the outcome of adjuvant chemoradiotherapy (CRT) after distal pancreatectomy (DP) in patients with pancreatic adenocarcinoma, and to identify the prognostic factors for these patients. MATERIALS AND METHODS: We performed a retrospective review of 62 consecutive patients who underwent curative DP followed by adjuvant CRT between 2000 and 2011. There were 31 men and 31 women, and the median age was 64 years (range, 38 to 80 years). Adjuvant radiotherapy was delivered to the tumor bed and regional lymph nodes with a median dose of 50.4 Gy (range, 40 to 55.8 Gy). All patients received concomitant chemotherapy, and 53 patients (85.5%) also received maintenance chemotherapy. The median follow-up period was 24 months. RESULTS: Forty patients (64.5%) experienced relapse. Isolated locoregional recurrence developed in 5 patients (8.1%) and distant metastasis in 35 patients (56.5%), of whom 13 had both locoregional recurrence and distant metastasis. The median overall survival (OS) and disease-free survival (DFS) were 37.5 months and 15.4 months, respectively. On multivariate analysis, splenic artery (SA) invasion (p=0.0186) and resection margin (RM) involvement (p=0.0004) were identified as significant adverse prognosticators for DFS. Also, male gender (p=0.0325) and RM involvement (p=0.0007) were associated with a significantly poor OS. Grade 3 or higher hematologic and gastrointestinal toxicities occurred in 22.6% and 4.8% of patients, respectively. CONCLUSION: Adjuvant CRT may improve survival after DP for pancreatic body or tail adenocarcinoma. Our results indicated that SA invasion was a significant factor predicting inferior DFS, as was RM involvement. When SA invasion is identified preoperatively, neoadjuvant treatment may be considered.
Adenocarcinoma*
;
Chemoradiotherapy, Adjuvant*
;
Disease-Free Survival
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Lymph Nodes
;
Maintenance Chemotherapy
;
Male
;
Multivariate Analysis
;
Neoadjuvant Therapy
;
Neoplasm Metastasis
;
Pancreatectomy*
;
Pancreatic Neoplasms
;
Radiotherapy, Adjuvant
;
Recurrence
;
Retrospective Studies
;
Splenic Artery*
7.Multidetector Computed Tomography for the Evaluation of Coronary Artery Disease; The Diagnostic Accuracy in Calcified Coronary Arteries, Comparing with IVUS Imaging.
Jong Kwan PARK ; Jong Youn KIM ; Hyuck Moon KWON ; Tae Hoon KIM ; Seung Jin OH ; Bum Kee HONG ; Young Won YOON ; Pil Ki MIN ; Sung Woo KWON ; Byoung Kwon LEE
Yonsei Medical Journal 2014;55(3):599-605
PURPOSE: Contrast enhanced multidetector computed tomography (MDCT) has been used as an alternative to coronary angiography for the assessment of coronary artery disease in the patient of the intermediate risk group. However, coronary calcium is a known limiting factor for MDCT evaluation. We investigated the diagnostic accuracy of 64-channel MDCT with each coronary artery calcium score (CACS) by compared with intravascular ultrasound (IVUS) imaging. MATERIALS AND METHODS: A total of 54 symptomatic patients with intermediate-risk (10 females, mean age 59.9+/-6.9 years, Framingham point scores 9-20) with 162 sites who had a culprit lesion on 64-channel MDCT before performing coronary angiography with IVUS were enrolled. Patients were divided into 4 subgroups depending on CACS: 0, 1-99, 100-399, and >400. Lesion length, external elastic membrane (EEM) cross sectional area (CSA), minimal luminal area, and plaque area were measured and compared between IVUS and MDCT. RESULTS: The correlation coefficients for the measurements of the EEM CSA, lumen CSA, and plaque area were r=0.514, r=0.837, and r=0.578, respectively. Furthermore, there were close correlation of plaque area between four subgroups of CACS (r=0.671, r=0.623, r=0.562, r=0.571, respectively). CONCLUSION: Despite the increase in CACS, the geometric analysis of coronary arteries using with 64-channel MDCT was comparable with IVUS in symptomatic patient of the intermediate risk group.
Aged
;
Coronary Artery Disease/*diagnosis/*radiography/ultrasonography
;
Female
;
Humans
;
Male
;
Middle Aged
;
Multidetector Computed Tomography/*methods
;
Predictive Value of Tests
;
Ultrasonography, Interventional/*methods
8.A Case of Metachronous Development of Esophageal Squamous Cell Carcinoma in the Patient with Esophageal Carcinosarcoma.
Ra Ri CHA ; Woon Tae JUNG ; Hye Won OH ; Hee Jin KIM ; Chang Yoon HA ; Hong Jun KIM ; Tae Hyo KIM ; Gyung Hyuck KO
The Korean Journal of Gastroenterology 2014;64(6):364-369
Esophageal carcinosarcoma is a rare malignant esophageal neoplasm consisting of both carcinomatous and sarcomatous elements, with an incidence of 0.5%. There have been only a few case reports of carcinosarcoma and squamous cell carcinoma coexisting in the esophagus. However, all of these are cases of synchronous or metachronous development of carcinosarcoma after chemoradiotherapy in patients of esophageal squamous cell carcinoma. A 53-year-old man underwent esophagogastroduodenoscopy because of chest pain for several months. Endoscopic examination revealed a huge pedunculated esophageal polypoid mass. Endoscopic submucosal dissection (ESD) was performed and histopathologic examination confirmed spindle cell carcinoma (carcinosarcoma). He refused additional esophagectomy. After 21 months, third follow-up endoscopy showed poorly-demarcated flat, faint discolored lesions at different location from the previous ESD site and endoscopic biopsies confirmed squamous cell carcinoma. To the best of our knowledge, this is the first case of metachronous development of esophageal squamous cell carcinoma in a patient with esophageal carcinosarcoma.
Antineoplastic Agents/therapeutic use
;
Carcinoma, Squamous Cell/*diagnosis/drug therapy/pathology
;
Carcinosarcoma/*diagnosis/drug therapy/pathology
;
Cisplatin/therapeutic use
;
Drug Therapy, Combination
;
Endoscopy, Digestive System
;
Esophageal Neoplasms/*diagnosis/drug therapy/pathology
;
Fluorouracil/therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Positron-Emission Tomography
;
S100 Proteins/metabolism
;
Tomography, X-Ray Computed
;
Tumor Suppressor Protein p53/metabolism
9.Bibliometric Analysis of the Journal of the Korean Society of Clinical Toxicology.
Jin Hyuck LEE ; Tae Ho LIM ; Won Hee KIM ; Chang Sun KIM ; Jae Hoon OH ; Hyung Goo KANG ; Hyuk Joong CHOI ; Bo Seung KANG
Journal of The Korean Society of Clinical Toxicology 2013;11(2):96-100
PURPOSE: The purpose of this study was to examine the research characteristics and the trend of the Journal of the Korean Society of Clinical Toxicology by bibliometric analysis. METHODS: This study was a retrospective quantitative literature review of the publications. We collected data from the internet homepage of the Korean Society of Clinical Toxicology. Among 228 publications, a total of 225 articles were included in this analysis. The data were analyzed from different perspectives, including article types, study design, number of authors, type of toxic material, and the top five ranking prolific authors and the affiliated organization were identified. RESULTS: A total of 225 articles were analyzed; 98(43.6%) were original articles, 115(51.1%) were case reports, and 12(5.3%) were reviews. Among the original articles, nine were prospective studies and 89 were retrospective studies, which were assorted according to study design; there were two(2.0%) cross sectional studies, 93(94.9%) cohort studies, and three(3.1%) etc. The median number of authors per article was five and the top five ranking authors and affiliated organizations published 31.1% and 32.8% of total articles, respectively. The most abundant topic was pesticides, followed by natural poisons and poisons encountered in the work place. CONCLUSION: Since its foundation, the Journal of the Korean Society of Clinical Toxicology has published 19 issues and 228 articles and has played a key role in development of toxicology research in Korea. However, low ratio of original articles and a decrease in the number of recent articles indicates that greater effort is needed in clinical research. In addition, further interest of many experts and various institutions is necessary.
Bibliometrics*
;
Cohort Studies
;
Cross-Sectional Studies
;
Internet
;
Korea
;
Pesticides
;
Poisons
;
Toxicology*
;
Workplace
10.Ischemic Compression After Trigger Point Injection Affect the Treatment of Myofascial Trigger Points.
Soo A KIM ; Ki Young OH ; Won Hyuck CHOI ; In Kyum KIM
Annals of Rehabilitation Medicine 2013;37(4):541-546
OBJECTIVE: To investigate the effects of trigger point injection with or without ischemic compression in treatment of myofascial trigger points in the upper trapezius muscle. METHODS: Sixty patients with active myofascial trigger points in upper trapezius muscle were randomly divided into three groups: group 1 (n=20) received only trigger point injections, group 2 (n=20) received trigger point injections with 30 seconds of ischemic compression, and group 3 (n=20) received trigger point injections with 60 seconds of ischemic compression. The visual analogue scale, pressure pain threshold, and range of motion of the neck were assessed before treatment, immediately after treatment, and 1 week after treatment. Korean Neck Disability Indexes were assessed before treatment and 1 week after treatment. RESULTS: We found a significant improvement in all assessment parameters (p<0.05) in all groups. But, receiving trigger point injections with ischemic compression group showed significant improvement as compared with the receiving only trigger point injections group. And no significant differences between receiving 30 seconds of ischemic compression group and 60 seconds of ischemic compression group. CONCLUSION: This study demonstrated the effectiveness of ischemic compression for myofascial trigger point. Trigger point injections combined with ischemic compression shows better effects on treatment of myofascial trigger points in the upper trapezius muscle than the only trigger point injections therapy. But the duration of ischemic compression did not affect treatment of myofascial trigger point.
Humans
;
Muscles
;
Myofascial Pain Syndromes
;
Neck
;
Pain Threshold
;
Range of Motion, Articular
;
Trigger Points

Result Analysis
Print
Save
E-mail